UK markets open in 5 hours 38 minutes

Establishment Labs Holdings Inc. (ESTA)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
48.54-0.41 (-0.84%)
At close: 04:00PM EDT
47.80 -0.74 (-1.52%)
After hours: 07:12PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close48.95
Open47.55
Bid48.44 x 100
Ask48.64 x 100
Day's range45.97 - 48.95
52-week range16.96 - 73.00
Volume188,892
Avg. volume395,000
Market cap1.344B
Beta (5Y monthly)1.25
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
All
News
  • Business Wire

    Establishment Labs to Announce First Quarter 2024 Financial Results on May 8

    NEW YORK, April 24, 2024--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the quarter ended March 31, 2024 after the market closes on Wednesday, May 8, 2024, and will host a conference call at 4:30 pm ET that day to discuss those results.

  • Business Wire

    Establishment Labs Announces Participation in The Aesthetic Meeting 2024

    NEW YORK, April 17, 2024--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced its participation in The Aesthetic Meeting 2024, which is being held May 2-5 in Vancouver, BC Canada.

  • Business Wire

    Establishment Labs Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Guidance

    NEW YORK, February 28, 2024--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced financial results for the fourth quarter and full year ended December 31, 2023 and provided 2024 guidance.